Literature DB >> 29545327

How I treat the postthrombotic syndrome.

Anat Rabinovich1, Susan R Kahn2,3.   

Abstract

The postthrombotic syndrome (PTS) is a chronic complication of deep vein thrombosis (DVT) that imposes significant morbidity, reduces quality of life, and is costly. After DVT, 20% to 50% of patients will develop PTS, and up to 5% will develop severe PTS. The principal risk factors for PTS are anatomically extensive DVT, recurrent ipsilateral DVT, obesity, and older age. By preventing the initial DVT and DVT recurrence, primary and secondary prophylaxis of DVT will reduce occurrence of PTS. The effectiveness of elastic compression stockings (ECSs) for PTS prevention is controversial. Catheter-directed thrombolysis is not effective to prevent PTS overall but may prevent more severe forms of PTS and should be reserved for select patients with extensive thrombosis, recent symptoms onset, and low bleeding risk. For patients with established PTS, the cornerstone of management is ECS, exercise, and lifestyle modifications. Surgical or endovascular interventions may be considered in refractory cases. Because of a lack of effective therapies, new approaches to preventing and treating PTS are needed. This article uses a case-based approach to discuss risk factors for PTS after DVT, how to diagnose PTS, and available means to prevent and treat PTS, with a focus on new information in the field.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2018        PMID: 29545327     DOI: 10.1182/blood-2018-01-785956

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.

Authors:  Susan R Kahn; Jim A Julian; Clive Kearon; Chu-Shu Gu; David J Cohen; Elizabeth A Magnuson; Anthony J Comerota; Samuel Z Goldhaber; Michael R Jaff; Mahmood K Razavi; Andrei L Kindzelski; Joseph R Schneider; Paul Kim; Rabih Chaer; Akhilesh K Sista; Robert B McLafferty; John A Kaufman; Brandt C Wible; Morey Blinder; Suresh Vedantham
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2020-01

2.  Resolvin D4 attenuates the severity of pathological thrombosis in mice.

Authors:  Deya Cherpokova; Charlotte C Jouvene; Stephania Libreros; Elise P DeRoo; Long Chu; Xavier de la Rosa; Paul C Norris; Denisa D Wagner; Charles N Serhan
Journal:  Blood       Date:  2019-10-24       Impact factor: 22.113

Review 3.  Thrombolytic therapy in acute venous thromboembolism.

Authors:  Thita Chiasakul; Kenneth A Bauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

4.  External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis.

Authors:  Anat Rabinovich; Chu-Shu Gu; Suresh Vedantham; Clive Kearon; Samuel Z Goldhaber; Heather L Gornik; Susan R Kahn
Journal:  J Thromb Haemost       Date:  2020-04-09       Impact factor: 5.824

5.  The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants.

Authors:  Paolo Prandoni; Walter Ageno; Maurizio Ciammaichella; Nicola Mumoli; Nello Zanatta; Davide Imberti; Adriana Visonà; Eugenio Bucherini; Marcello Di Nisio; Franco Noventa
Journal:  Intern Emerg Med       Date:  2019-10-30       Impact factor: 3.397

6.  Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis.

Authors:  Lisette F van Dam; Wilbert B van den Hout; Gargi Gautam; Charlotte E A Dronkers; Waleed Ghanima; Jostein Gleditsch; Anders von Heijne; Herman M A Hofstee; Marcel M C Hovens; Menno V Huisman; Stan Kolman; Albert T A Mairuhu; Mathilde Nijkeuter; Marcel A van de Ree; Cornelis J van Rooden; Robin E Westerbeek; Jan Westerink; Eli Westerlund; Lucia J M Kroft; Frederikus A Klok
Journal:  Blood Adv       Date:  2021-03-09

7.  Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.

Authors:  Wenzhu Li; Chase W Kessinger; Makoto Orii; Hang Lee; Lang Wang; Ido Weinberg; Michael R Jaff; Guy L Reed; Peter Libby; Ahmed Tawakol; Peter K Henke; Farouc A Jaffer
Journal:  Circulation       Date:  2021-01-15       Impact factor: 29.690

Review 8.  Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review.

Authors:  Ke Xuan Li; Gisele Diendéré; Jean-Philippe Galanaud; Nada Mahjoub; Susan R Kahn
Journal:  Res Pract Thromb Haemost       Date:  2021-05-08

9.  Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Predicts Vein Wall Scarring and Statin Benefit in Murine Venous Thrombosis.

Authors:  Chase W Kessinger; Guanming Qi; Malek Z O Hassan; Peter K Henke; Ahmed Tawakol; Farouc A Jaffer
Journal:  Circ Cardiovasc Imaging       Date:  2021-03-16       Impact factor: 7.792

10.  American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

Authors:  Thomas L Ortel; Ignacio Neumann; Walter Ageno; Rebecca Beyth; Nathan P Clark; Adam Cuker; Barbara A Hutten; Michael R Jaff; Veena Manja; Sam Schulman; Caitlin Thurston; Suresh Vedantham; Peter Verhamme; Daniel M Witt; Ivan D Florez; Ariel Izcovich; Robby Nieuwlaat; Stephanie Ross; Holger J Schünemann; Wojtek Wiercioch; Yuan Zhang; Yuqing Zhang
Journal:  Blood Adv       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.